Literature DB >> 11875461

NF-kappaB at the crossroads of life and death.

Michael Karin1, Anning Lin.   

Abstract

The choice between life and death is one of the major events in regulation of the immune system. T cells that specifically recognize viral or bacterial antigens are selected to survive and proliferate in response to infection, whereas those that are self-reactive are eliminated via apoptosis. Even the survival of alloreactive T cells requires their proper costimulation and, when infection subsides, the activated T cells are eliminated. A major regulator of such life or death decisions is the transcription factor NF-kappaB. However, NF-kappaB cannot function alone. A variety of mechanisms exist to modulate its activity and thereby affect the ultimate outcome of a cell's fate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11875461     DOI: 10.1038/ni0302-221

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  851 in total

1.  The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo.

Authors:  Mi-Ae Lyu; Deepak Rai; Kwang Seok Ahn; Bokyung Sung; Lawrence H Cheung; John W Marks; Bharat B Aggarwal; Ricardo C T Aguiar; Varsha Gandhi; Michael G Rosenblum
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.

Authors:  L A O'Reilly; P Hughes; A Lin; P Waring; U Siebenlist; R Jain; D H D Gray; S Gerondakis; A Strasser
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

3.  Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis.

Authors:  Bao-Song Zhu; Chun-Gen Xing; Fang Lin; Xiao-Qing Fan; Kui Zhao; Zheng-Hong Qin
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

4.  Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.

Authors:  Sima Z Torabian; David de Semir; Mehdi Nosrati; Sepideh Bagheri; Altaf A Dar; Sylvia Fong; Yong Liu; Scot Federman; Jeff Simko; Chris Haqq; Robert J Debs; Mohammed Kashani-Sabet
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

5.  Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl.

Authors:  Hidehiko Kawai; Linghu Nie; Zhi-Min Yuan
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

6.  TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.

Authors:  You-Sun Kim; Sergei A Nedospasov; Zheng-Gang Liu
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.

Authors:  Rüdiger Arnold; Irene M Patzak; Brit Neuhaus; Sadia Vancauwenbergh; André Veillette; Johan Van Lint; Friedemann Kiefer
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  Regulation of Linear Ubiquitin Chain Assembly Complex by Caspase-Mediated Cleavage of RNF31.

Authors:  Donghyun Joo; Yong Tang; Marzenna Blonska; Jianping Jin; Xueqiang Zhao; Xin Lin
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

9.  Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.

Authors:  Ping Hu; Zhang Han; Anthony D Couvillon; Randal J Kaufman; John H Exton
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation.

Authors:  Sanghoon Lee; Charlotte Andrieu; Frédéric Saltel; Olivier Destaing; Jessie Auclair; Véronique Pouchkine; Jocelyne Michelon; Bruno Salaun; Ryuji Kobayashi; Pierre Jurdic; Elliott D Kieff; Bakary S Sylla
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.